Convergence Infufficency Treatment Trial - Attention and Reading Trial (CITT-ART)
Convergence Infufficency Treatment Trial - Attention and Reading Trial (CITT-ART)
批准号:
9269208
负责人:
MARJEAN T KULP
金额:
$0.0万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
2014
资助国家:
美国
项目状态:
已结题
起止时间:
2014-05-01 至 2019-04-30
关键词:
AdherenceAdvertisementsAdvertisingAftercareAreaAttentionAttention deficit hyperactivity disorderBehaviorBinocular VisionCaringCastanea dentataChildChild CareClinicalClinical TrialsCognitiveCommunitiesConsentConvergence InsufficiencyDataData Coordinating CenterDevelopmentDocumentationEducational CurriculumEligibility DeterminationEnrollmentEnsureEquipmentEthicsEvaluationEyeFutureGood Clinical PracticeHealth Insurance Portability and Accountability ActHealth ProfessionalHelsinki DeclarationHome environmentHuman ResourcesIndividualInvestigationLegLettersLong-Term EffectsManualsMasksMeasuresMethodsNewspapersOhioOphthalmologyOptometryOutcomeOutcome MeasureParentsParticipantPatientsPediatricsPennsylvaniaPerformancePhysiciansPlacebo ControlPlacebosPoliciesPrivacyProceduresProtocols documentationPsychological reinforcementPsychologistPublicationsQuality ControlRandomizedRandomized Clinical TrialsReadingRecordsRecruitment ActivityReportingResearchResearch PersonnelScheduleServicesSiteSurveysSymptomsTestingTraining and EducationUnderrepresented MinorityUniversitiesVision DisordersVisitachievement testagedbasecollegecostdesignexperiencefollow-uphuman subject protectioninterestlistening comprehensionnewsprimary outcomereading abilityreading comprehensionsecondary outcomesymptom treatmentteachertreatment effecttreatment grouptreatment programtreatment trialtrial designwaiverweb site
中文摘要
点击翻译按钮获取中文摘要
英文摘要
DESCRIPTION (provided by applicant): This proposal is for The OSU College of Optometry Clinical Center to serve as a clinical center for the Convergence Insufficiency Treatment Trial - Attention and Reading Trial (CITT-ART), a multicenter randomized, placebo controlled, clinical trial designed to evaluate the effects of treatment for symptomatic convergence insufficiency (Cl) on measures of reading performance and attention in children. 'In this trial, 324 children aged 9 to <14 years with symptomatic Cl will be randomly assigned to 16 weeks of: 1) office-based vergence/ accommodative therapy with home-reinforcement or 2) office-based placebo therapy. After 16 weeks of treatment, the primary outcome measures of reading comprehension (Wechsler Individual Achievement test [WIAT-lll] reading comprehension subtest score) and attention (Strengths and Weaknesses of ADHD Symptoms & Normal Behavior Scale [SWAN]) will be assessed by examiners masked to treatment group. The Gates MacGinitie-4 test, which uses a format similar to curriculum-based evaluation done in classrooms, will provide a secondary measure of reading comprehension. Reading fluency, another test of attention, the Cl Symptom Survey, and clinical measures of Cl (i.e., the near point of convergence, and positive fissional vergence at near) will be other secondary outcome measures; also included will be assessments of key reading and cognitive components that impact reading comprehension including pseudo word decoding, word reading, and listening comprehension. Long-term effects on reading achievement and attention will be assessed 1-year post treatment. This application documents our site's ability to recruit at least 36 subjects and to retain them fo 1 year after completion of treatment. Documentation is provided that our site has the appropriate personnel, equipment, and facilities to conduct the study in accordance with the CITT-ART Manual of Procedures (MOP). Complete details of the study rationale, design, and methods are contained in the Manual of Procedures (submitted with the Study Chair and Data Coordinating Center [DCC] applications). In addition to our center, there are 8 other optometric or ophthalmologic centers, the Study Chair at the Pennsylvania College of Optometry at Salus University, and the DCC at The Ohio State University Optometry Coordinating Center. Symptomatic Cl is a common vision disorder in children that is commonly associated with symptoms while reading (e.g. loss of place, loss of concentration, frequent re-reading, reading 'slowly,-trouble remembering what was read). However, the effect of Cl treatment on reading and attention is unknown. The results of the proposed study will lead to a better understanding of these relationships and have important implications for educators, psychologists, and physicians who care for children with reading and attention problems. The findings will guide hypothesis development for future scientific investigations in children with vision disorders.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Convergence Infufficency Treatment Trial - Attention and Reading Trial (CITT-ART)
-
批准号:8838807
-
项目类别:
-
资助金额:$22.83万
-
财政年份:2014
-
负责人:MARJEAN T KULP
-
依托单位:
Convergence Infufficency Treatment Trial - Attention and Reading Trial (CITT-ART)
-
批准号:9094591
-
项目类别:
-
资助金额:$15.92万
-
财政年份:2014
-
负责人:MARJEAN T KULP
-
依托单位:
Convergence Infufficency Treatment Trial - Attention and Reading Trial (CITT-ART)
-
批准号:8609308
-
项目类别:
-
资助金额:$21.5万
-
财政年份:2014
-
负责人:MARJEAN T KULP
-
依托单位:
Vision In Preschoolers - Hyperopia in Children (VIP-HIP)
-
批准号:8265250
-
项目类别:
-
资助金额:$73.37万
-
财政年份:2011
-
负责人:MARJEAN T KULP
-
依托单位:
Vision In Preschoolers - Hyperopia in Children (VIP-HIP)
-
批准号:8026170
-
项目类别:
-
资助金额:$78.86万
-
财政年份:2011
-
负责人:MARJEAN T KULP
-
依托单位:
Vision In Preschoolers - Hyperopia in Children (VIP-HIP)
-
批准号:8536484
-
项目类别:
-
资助金额:$33.56万
-
财政年份:2011
-
负责人:MARJEAN T KULP
-
依托单位:
Convergence Insufficiency Treatment Trial
-
批准号:6728074
-
项目类别:
-
资助金额:$12.6万
-
财政年份:2004
-
负责人:MARJEAN T KULP
-
依托单位:
Convergence Insufficiency Treatment Trial
-
批准号:7050261
-
项目类别:
-
资助金额:$3.25万
-
财政年份:2004
-
负责人:MARJEAN T KULP
-
依托单位:
Convergence Insufficiency Treatment Trial
-
批准号:6954632
-
项目类别:
-
资助金额:$15.72万
-
财政年份:2004
-
负责人:MARJEAN T KULP
-
依托单位:
Convergence Insufficiency Treatment Trial
-
批准号:7117226
-
项目类别:
-
资助金额:$7.35万
-
财政年份:2004
-
负责人:MARJEAN T KULP
-
依托单位:
VISION SCREENING IN PRESCHOOLERS/TOSU CLINICAL CENTER
-
批准号:6805239
-
项目类别:
-
资助金额:$14.57万
-
财政年份:2000
-
负责人:MARJEAN T KULP
-
依托单位:
海外基金